Abstract
Five vervet monkeys were administered increasing doses (4–12 mg/kg/day) of d-amphetamine over a period of 35 days. Three phases of behavioural change were discerned: phase 1 during which animals exhibited repetitive stereotyped action sequences with rapid head movements, occasional abnormal grooming, picking at the cage, hand-staring and snatching; phase 2 in which behaviour became progressively more restricted and animals became markedly unresponsive to auditory, visual and tactile stimuli; phase 3 was characterised by the abrupt development of gross over-responsiveness to environmental stimuli, ataxia and tremor. At post-mortem, by comparison with controls, amphetamine-treated monkeys showed marked depletions of the monoamines dopamine (DA), noradrenaline (NA) and serotonin (5-HT) in corpus striatum and cerebral cortex and reductions in the activities of tyrosine hydroxylase and dopa decarboxylase in striatum. Turnover of these monoamines, assessed by high-performance liquid chromatography determinations of their respective metabolites, was also reduced. These findings are interpreted as evidence of monoamine neurone destruction, most severely in the case of DA neurones. Though there was a non-significant reduction in 3H-spiperone binding (reaching almost 50% in nucleus accumbens), numbers of receptors for the monoamines NA and 5-HT were not significantly changed, and the activities of the enzymes choline acetyl-transferase and glutamine decarboxylase were similar in experimental and control animals. The contrast of these findings with those seen in post-mortem brains in schizophrenia is discussed.
Similar content being viewed by others
References
Bennett JB, Snyder SH (1975) Stereospecific binding of d-lysergic acid diethylamide (LSD) to brain membrane: Relationship to serotonin receptors. Brain Res 94:523–544
Bylund DB, Snyder SH (1976) Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580
Carlsson A (1974) Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine. Adv Biochem Pharmacol 10:75–81
Connell PH (1958) Amphetamine psychosis. Maudsley Monogr 5. Chapman and Hall, London
Coyle JT, Henry D (1973) Catecholamines in foetal and newborn rat brain. J Neurochem 21:61–67
Cross AJ, Joseph MH (1981) The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection. Life Sci 28:499–505
Crow TJ, Baker HF, Cross AJ, Joseph MH, Lofthouse R, Longden A, Owen F, Riley GJ, Glover V, Killpack WS (1978) Monoamine mechanisms in chronic schizophrenia: Post mortem neurochemical findings. Br J Psychiatry 134:249–256
Eibergen RD, Carlson KR (1976) Dyskinesias in monkeys: Interaction of methamphetamine with prior methadone treatment. Pharmacol Biochem Behav 5:175–187
Ellinwood EH (1972) Amphetamine psychosis: Individuals, settings and sequences. In: Ellinwood EH (ed) Current concepts on amphetamine abuse. NIMH, Baltimore, pp 143–157
Ellinwood EH, Kilbey MM (1975) Amphetamine stereotypy: The influence of environmental factors and prepotent behavioural patterns on its topography and development. Biol Psychiatry 10:3–16
Ellinwood EH, Sudilovsky A, Nelson LM (1973) Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 130:1088–1093
Ellison G, Eison MS, Huberman HS (1978) Stages of constant amphetamine intoxication: Delayed appearance of abnormal social behavior in rat colonies. Psychopharmacology 56:293–299
Ellison G, Nielsen FB, Lyon M (1981) Animal model of psychosis: Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. J Psychiatr Res 16:13–22
Fog R (1970) Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs. Psychopharmacologia 16:305–312
Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407–409
Friedhoff AJ, Alpert MA (1973) A dopaminergic-cholinergic mechanism in the production of psychotic symptoms. Biol Psychiatry 6:165–169
Garver DL, Schlemmer RF, Maas JW, Davis JM (1975) A schizophreniform behavioral psychosis mediated by dopamine. Am J Psychiatry 132:33–38
Griffiths JD, Cavanaugh J, Held J, Oates JA (1972) Dextramphetamine: Evaluation of psychomimetic properties in man. Arch Gen Psychiatry 26:97–100
Janowsky DS, Risch C (1979) Amphetamine psychosis and psychotic symptoms. Psychopharmacology 65:73–77
Kjellberg B, Randrup A (1972) Stereotypy with selective stimulation of certain items of behavior observed in amphetamine-treated primate monkeys. Pharmakopsychiatr Neuropsychopharmakol 5:1–12
Lerner P, Hartmann P, Ames MM, Lovenberg G (1977) The role of reductants in the tyrosine hydroxylase reaction. Arch Biochem Biophys 182:164–170
McCamen MW, McCamen RE, Lees GJ (1972) Liquid cation exchange: A basis for sensitive radiometric assay for aromatic amino acid decarboxylase. Anal Biochem 45:242–252
Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 2:19–76
Moore KE (1977) The actions of amphetamine on neurotransmitters: A brief review. Biol Psychiatry 12:451–462
Owen F, Baker HF, Ridley RM, Cross AJ, Crow TJ (1981) Effect of chronic amphetamine administration on central dopaminergic mechanisms in the vervet. Psychopharmacology 74:213–216
Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ (1978) Increased dopamine-receptor sensitivity in schizophrenia. Lancet II:223–226
Randrup A, Munkvad I (1965) Special antagonism of amphetamine-induced abnormal behaviour: Inhibition of sterotyped activity with increase of some normal activities. Psychopharmacologia 7:416–422
Ridley RM, Baker HF (1982) Stereotypy in monkeys and humans. Psychol Med 12:61–72
Ridley RM, Baker HF, Crow TJ (1980) Behavioral effects of amphetamine and related stimulants: The importance of species differences as demonstrated by a study in the marmoset. In: Caldwell J (ed) Amphetamines and related stimulants: Chemical, biological, clinical and sociological aspects. CRC Press, Boca Raton, FL, pp 97–116
Ridley RM, Baker HF, Scraggs PR (1979) The time course of the behavioural effects of amphetamine and their reversal by haloperidol in a primate species. Biol Psychiatry 14:753–765
Roberts E (1972) An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Prog Bull 10:468–482
Rylander G (1972) Psychosis and the punding and choreiform syndromes in addiction to central stimulant drugs. Folia Psychiatr Neurol Neurochir 75:203–212
Saavedra JM, Brownstein M, Axelrod J (1973) A specific and sensitive enzymatic isotopic microassay for serotonin in tissues. J Pharmacol Exp Ther 186:508–515
Schiørring E (1971) Amphetamine-induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open field test with rats. Behavior 39:1–17
Schiørring E (1979) Social isolation and other behavioral changes in groups of adult vervet monkeys (Cercopithecus aethiops) produced by low, nonchronic doses of d-amphetamine. Psychopharmacology 64:297–302
Seeman P, Westman K, Coscina D, Warsh JJ (1980) Serotonin receptors in hippocampus and frontal cortex. Eur J Pharmacol 66:179–191
Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249–255
Trulson ME, Jacobs BL (1979a) Chronic amphetamine administration to cats: Behavioural and neurochemical evidence for decreased central serotonergic function. J Pharmacol Exp Ther 211:375–383
Trulson ME, Jacobs BL (1979b) Long-term amphetamine treatment decreases brain serotonin metabolism: Implication for theories of schizophrenia. Science 205:1295–1297
Trulson ME, Jacobs BL (1980) Chronic amphetamine administration decreases brain tryptophan hydroxylase activity in cats. Life Sci 26:329–335
U'Pritchard DC, Bechtel WD, Rovot B, Snyder SH (1979) Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: Effect of 6-hydroxydopamine. Mol Pharmacol 16:47–60
U'Pritchard DC, Snyder SH (1979) Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sci 24:79–88
Waddington JL, Cross AJ (1978) Neurochemical changes following kainic acid lesions of the nucleus accumbens: Implications for a GABAergic accumbal-ventral tegmental pathway. Life Sci 22:1101–1106
Wagner GC, Ricaute GA, Johanson CE, Schuster CR, Seiden LS (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30:547–550
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ridley, R.M., Baker, H.F., Owen, F. et al. Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology 78, 245–251 (1982). https://doi.org/10.1007/BF00428159
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00428159